Bioanalysis
Our Bioanalytical Services Department offers scientific excellence, uncompromised quality and unbeatable timelines to meet and exceed client needs.
Our GLP-compliant bioanalytical Canadian facility is 20,000 sq feet (1850 sq metres), with 24 LC-MS/MS systems (19 API3000 & 5 API5000 operating 24/7), 5 LC-MS, 9 UV detectors and 5 fluorescence detectors. It is fully equipped with a dedicated method development group and multiple state-of-the-art resources, ensuring a straightforward and compliant submission for any country.
Our wealth of bioanalytic experience has been gained across different matrices, including plasma, serum, whole blood, urine, cerebro-spinal fluid, tissues and faeces. We also have experience in multi-sites studies, complex sample receipt and identification, concomitant medications, communication with external sites and more. Our highly trained employees are governed by and fully adhere to the highest quality standards including GLP (Good Lab Practices) and international regulations.
The Bioanalytical Services Department size allows us to quickly scale for flexibility and expedited validation and sample analysis, all while maintaining our rigorous Quality Assurance processes.
We are proud of our accurate and reliable results. Our batch & Incurred Sample Reanalysis (ISR) success rate is excellent (95%-100%), which attests to our high standards and uncompromising quest for consistent perfection in our lab work.
Our GLP-compliant bioanalytical UK facility is 10,000 sq feet (925 sq metres), with 5 LC-MS/MS instruments and 2 LC-MS instruments in operation as well as GC-MS.
Biomarker assays using enzyme- (ELISA) and radioimmunoassay (RIA) techniques are also an increasingly important area of work. We have a Radioisotopes laboratory which performs radioactivity measurements for human ADME and Mass Balance studies. Radio-HPLC and MS-MS techniques are used to investigate metabolite profiles and to assist the identification of putative metabolites.
Combined, our bioanalytical facilities share more than 500 validated methods for drugs, metabolites and biomarkers in biological matrices, covering most therapeutic areas.
Close relationship with clients
Our team maintains a strong relationship-focused approach. Maintaining good communication and a close relationship with our clients are paramount to us.
We provide regular updates from the scientist assigned to your project during method development. We also facilitate meetings, teleconferences or videoconferences to discuss our procedures and testing, if required. If desired, a specific team is designated for all your studies, and you will have direct communication with the team manager for accurate, timely information.
